6 completed. 6 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
Follow Cenobamate: new trials by email Literature Review of Cenobamate trials Research Report on Cenobamate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered Orally Cenobamate - Healthy Volunteers | Phase 1 | Completed | SK Life Science, Inc. | 24 | 2022-09-27 | 2024-09-19 |
| Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment Cenobamate - Hepatic Impairment | Phase 1 | Completed | SK Life Science, Inc. | 15 | 2021-06-17 | 2024-03-28 |
| Dose-Escalation Study of Cenobamate (YKP3089) in Pediatric Subjects With Partial-Onset Seizures Xcopri - Partial Epilepsy | Phase 1 | Completed | SK Life Science, Inc. | 26 | 2021-05-27 | 2026-03-31 |
| Bioavailability and Food Effect Study of Cenobamate as an Oral Suspension and Tablet Cenobamate 200Mg Tab Fasted, Cenobamate Oral Suspension Fed, Cenobomate Oral Suspension Fasted - Healthy | Phase 1 | Completed | SK Life Science, Inc. | 28 | 2020-12-21 | 2024-08-12 |
| A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users Alprazolam Placebo, Cenobamate placebo, Alprazolam - Healthy Volunteer | Phase 1 | Completed | SK Life Science, Inc. | 53 | 2017-03-08 | 2024-11-07 |
| Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions Cenobamate, midazolam, Warfarin Pill - Healthy | Phase 1 | Completed | SK Life Science, Inc. | 24 | 2017-02-22 | 2024-09-19 |
Epilepsies, Partial (1) · Seizures (1)
United States (5) · Canada (1) · Hungary (1) · Poland (1) · Slovakia (1) · South Korea (1)
Janice Laramy, PhD, PharmD (1) · Stephen Greene, PharmD (1) · Sunita Misra, MD (1) · Vijaykumar Vashi (1)